0 96

Cited 3 times in

Identification of human papillomavirus status specific biomarker in head and neck cancer

Authors
 Ki-Yeol Kim  ;  Xianglan Zhang  ;  In-Ho Cha 
Citation
 Head & Neck, Vol.37(9) : 1310-1318, 2015 
Journal Title
 Head & Neck 
ISSN
 1043-3074 
Issue Date
2015
MeSH
Adult ; Aged ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/physiopathology ; Carcinoma, Squamous Cell/virology* ; DNA, Viral/genetics* ; Databases, Factual ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Viral ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/physiopathology ; Head and Neck Neoplasms/virology* ; Humans ; Male ; Microarray Analysis ; Middle Aged ; Papillomaviridae/genetics* ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/genetics* ; Prognosis ; Reproducibility of Results ; Risk Assessment ; Sampling Studies ; Sensitivity and Specificity ; Statistics, Nonparametric
Keywords
head and neck cancer ; human papillomavirus ; human papillomavirus (HPV) status-specific gene set ; microarray data ; prognosis
Abstract
BACKGROUND: In an attempt to improve the prognosis of patients with head and neck cancer, it could be necessary to identify biomarkers in homogeneous subgroups of patients with head and neck cancer. METHODS: We explored the necessity of human papillomavirus (HPV) status-specific biomarkers in patients with head and neck cancer and identified an HPV status-specific gene set. The identified gene set was validated with the external microarray datasets. For this purpose, we used 4 microarray datasets obtained from a public database. One dataset was used for identifying the HPV status specific gene set, and the other datasets were used for validation. RESULTS: The identified gene set for distinguishing head and neck cancer from head and neck normal, did not accurately discriminate the HPV specific patients with head and neck cancer from the head and neck normal group. Also, it was demonstrated that some HPV-positive (HPV+) head and neck cancer-specific genes may not be significant in HPV-negative (HPV-) head and neck cancer patients. The identified HPV specific gene sets showed good performance in validation datasets. The HPV+ head and neck cancer-specific gene set included various metabolism-related pathways, and the HPV- head and neck cancer-specific gene set included several pathways; fibroblast, collagen degradation, actin-binding, and actin cytoskeleton. CONCLUSION: The identification of HPV status-specific significant gene set was necessary. It is expected that HPV status-specific biomarkers can be helpful in deciding therapeutic methods for patients with head and neck cancer, after biological validation and large prospective trials.
Full Text
http://onlinelibrary.wiley.com/doi/10.1002/hed.23751/abstract
DOI
10.1002/hed.23751
Appears in Collections:
1. Journal Papers (연구논문) > 5. Research Institutes (연구소) > Oral Cancer Research Institute (구강종양연구소)
1. Journal Papers (연구논문) > 2. College of Dentistry (치과대학) > Dept. of Oral and Maxillofacial Surgery (구강악안면외과학교실)
Yonsei Authors
김기열(Kim, Ki Yeol) ORCID logo https://orcid.org/0000-0001-5357-1067
장향란(Zhang, Xiang Lan)
차인호(Cha, In Ho) ORCID logo https://orcid.org/0000-0001-8259-2190
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/157002
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse